These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1217381)

  • 21. [Features of the clinical picture, course and treatment of myasthenia in late middle-aged and aged persons].
    Gladyshev SS; Gekht BM; Kolomenskaia EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1633-8. PubMed ID: 3811723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab for myasthenia gravis: three case reports and review of the literature.
    Stieglbauer K; Topakian R; Schäffer V; Aichner FT
    J Neurol Sci; 2009 May; 280(1-2):120-2. PubMed ID: 19272616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myasthenia gravis and pregnancy].
    Snijders MP; de Graaff J; Op de Coul AA
    Ned Tijdschr Geneeskd; 1987 Jul; 131(28):1225-7. PubMed ID: 3614418
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pulmonary volumes and capacities in extremely severe forms of malignant myasthenia under multiyear treatment with alternating doses of prednisolone and artificial pulmonary ventilation].
    Popova LM; Oganesian ShS; Vinitskaia RS
    Anesteziol Reanimatol; 1979; (3):11-6. PubMed ID: 475040
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
    Pascuzzi RM; Coslett HB; Johns TR
    Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cell electrophoretic studies of lymphocytes. 3. Effects of administration of a massive dosage of prednisolone on lymphocyte functions in myasthenia gravis].
    Noguchi S
    Rinsho Shinkeigaku; 1976 May; 16(5):373-80. PubMed ID: 986275
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis and treatment of myasthenia gravis. Experience 1974-1992].
    Rey RD; Buzzi AE; Astudillo MA; Díaz G; Losavio A; Muchnik S; Sanz OP; Sica RE
    Medicina (B Aires); 1995; 55(1):11-20. PubMed ID: 7565029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration.
    Tanaka S; Masuda M; Nakajima K; Ido N; Ohtsuka T; Nishida M; Utsumi H; Hirano T
    Int Immunopharmacol; 2009 Mar; 9(3):284-90. PubMed ID: 19101657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and adverse effects of using large doses of corticosteroid preparations administered every other day].
    Kolomenskaia EA; Andreeva II; Ibragimova GV; Odintsova TA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(4):531-6. PubMed ID: 6305069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Massive prednisolone administration in myasthenia gravis--electrophysiological examination].
    Yanagizawa N; Shoji S; Tsukagoshi H; Toyokura Y
    Nihon Rinsho; 1973 Feb; 31(2):321-6. PubMed ID: 4737112
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical importance of the electron microscopic study of muscle biopsies in myasthenia during prednisolone therapy].
    Pal'tsev MA; Popova LM
    Arkh Patol; 1981; 43(1):52-8. PubMed ID: 7213083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Splenectomy in the treatment of severe generalized myasthenia gravis (first experience)].
    Kuzin MI; Shkrob OS; Gekht BM; Vetshev PS; Shagal DI; Zaĭrat'iants OV; Khodzhaev ZSh; Ippolitov IKh
    Khirurgiia (Mosk); 1990 Aug; (8):95-9. PubMed ID: 2259184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapetic measures in myasthenia gravis].
    Cavaciuti P; Gatti E
    Minerva Anestesiol; 1969 Aug; 35(8):765-79. PubMed ID: 5364124
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pre- and postoperative care of thymectomy in patients with myasthenia gravis].
    Yoshimatsu H; Ishikura Y; Murakami M; Kawahara H; Nagata M
    Rinsho Kyobu Geka; 1982; 2(3):445-50. PubMed ID: 7156751
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.
    Ricciardi R; Rossi B; Nicora M; Sghirlanzoni A; Muratorio A
    J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1061-2. PubMed ID: 1783916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pneumatosis intestinalis in a patient of myasthenia gravis treated with high-dose corticosteroid].
    Kameyama K; Noguchi Y; Matsumoto T; Takenawa H; Fujigasaki H; Kanda T; Mizusawa H
    Rinsho Shinkeigaku; 2003 May; 43(5):277-80. PubMed ID: 12931635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical manifestations of myasthenia gravis - review of cases seen at the Lagos University Teaching Hospital.
    Ojini FI; Danesi MA; Ogun SA
    Niger Postgrad Med J; 2004 Sep; 11(3):193-7. PubMed ID: 15505649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients.
    Richaud-Patin Y; Vega-Boada F; Vidaller A; Llorente L
    Biomed Pharmacother; 2004 Jun; 58(5):320-4. PubMed ID: 15194168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile myasthenia gravis and thymectomy: report of ten cases.
    de Assis JL; Marchiori PE; Zambon AA; Scaff M
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(5):234-6. PubMed ID: 1340608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.